Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-19-011567

Chief Executive Officer sold 20,000 shares at $42.03 ($840,600)

  • Chief Executive Officer acquired 20,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kulkarni Samarth Chief Executive Officer 2019-04-29 Option exercise +20,000 $1.81 $36,200 186,542 D
Kulkarni Samarth Chief Executive Officer 2019-04-29 Sale −20,000 $42.03 $840,600 166,542 D
Derivatives
Kulkarni Samarth Chief Executive Officer 2019-04-29 Option exercise · Stock Option (Right to Buy) −20,000 223,058 D
Open-market sales · 20,000 sh · avg $42.03 · $840,600
Loading xslF345X03/doc4.xml…